Association of long term sodium valproate monotherapy and vitamin D3 levels in epileptic children

  • Anum Shah
  • Imran Mahmood Khan Islamabad Medical and Dental College
  • Sajid Hussain Sherazi
  • Taniah Ashfaq
  • Sajid Hussain Shah
Keywords: Epilepsy, sodium valproate, vitamin D3 deficiency


Objective: To determine the association of long term sodium valproate monotherapy and vitamin D3 levels in epileptic children

Methods: This cross-sectional study was conducted in the Department of Pediatrics, Children Hospital, Pakistan Institute of Medical Sciences, Islamabad for six months from 15th February 2019 to 14th August 2019. A total of one hundred and thirty (n=130) children and adolescents of either gender between age 3-18 years who had a history of two seizures at least 24 hours apart in their life and were on sodium valproate monotherapy for more than one year were enrolled in this study through non-probability, consecutive sampling. Serum vitamin D3 (25-hydroxy vitamin D) levels were measured in all the patients at the time of enrolment into the study. All the demographic data and laboratory investigations were entered on the predesigned proforma and analyzed through SPSS version 17.

Results: Vitamin D3 deficiency was found in 47 (36.2%) children which were significantly higher among patients with older age and longer duration of treatment (P<0.05) while gender and BMI of the patients did not show any significant difference (P>0.05).

Conclusion: Significant percentage of epileptic children on sodium valproate monotherapy was found to have vitamin D3 deficiency. Therefore we recommend routine screening of vitamin D3 deficiency in all the epileptic children on long-term sodium valproate therapy followed by vitamin D supplementation in deficient patients.



1. Borusiak P, Zilbauer M, Jenke AC. Prevalence of epileptiform discharges in healthy children—new data from a prospective study using digital EEG. Epilepsia. 2010 Jul;51(7):1185-8.
2. Fan H-C, Lee H-S, Chang K-P, Lee Y-Y, Lai H-C, Hung P-L, et al. The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. Int J Mol Sci [Internet]. 2016 Aug 1;17(8):1242.
3. Aziz H, Ali SM, Frances P, Khan MI, Hasan KZ. Epilepsy in Pakistan: A Population-Based Epidemiologic Study. Epilepsia 1994;35(5):950–8.
4. Malik MA, Akram RM, Tarar MA, Sultan A. Childhood epilepsy. J Coll Physicians Surg Pak [Internet]. 2011;21(2):74–8.
5. Chaudhuri JR, Mridula KR, Rathnakishore C, Balaraju B, Bandaru VS. Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients. Iran J Child Neurol [Internet]. 2017;11(2):48–56.
6. Taha Abdullah A, Taher Mousheer Z. Vitamin D Status in Epileptic Children on Valproic Acid; a Case-Control Study. Arch Acad Emerg Med 2020;8(1):13.
7. Tomita S, Ohnishi J ichi, Nakano M, Ichikawa Y. The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systems. J Steroid Biochem Mol Biol 1991;39(4 PART 1):479–85.
8. Kija E, Gidal BE, Shapson-Coe A, Cader S, Van Der Watt G, Delport S, et al. Vitamin D abnormalities and bone turn over analysis in children with epilepsy in the Western Cape of South Africa. Seizure Eur J Epilepsy 2019;69:186–92.
9. Valvi C, Daga S, Kabade U, Agarwal M. Childhood epilepsy: Management in resource-limited setting. Ann Indian Acad Neurol 2008;11(1):33–6.
10. Razazizan N, Mirmoeini M, Daeichin S, Ghadiri K. Comparison of 25-hydroxy vitamin D, calcium and alkaline phosphatase levels in epileptic and non-epileptic children Surgical Management of the Cesarean Scar Ectopic Pregnancy: A Case Report View project Molecular Typing of Klebsiella pneumoniae Isolated f. Acta Neurol Taiwan 2013;22(3):112–6.
11. Rafiq M, Bano S, Tariq PA. EFFECTS OF ANTIEPILEPTIC DRUG THERAPY ON 25OH VITAMIN D LEVELS. Pak J Physiol 2015;11(4):24–30.
12. Sreedharan M, Devadathan K, Kunju M. Vitamin D Deficiency in Ambulant Children on Carbamazepine or Sodium Valproate Monotherapy - PubMed. Indian Pediatr 2018;55(4):307–10.
13. Ginige N, De Silva KSH, Wanigasinghe JK, Gunawardane NS, Munasinghe TMJ. Effects of long term anti epileptic drugs on serum vitamin D levels and bone profile in a cohort of Sri Lankan children. Int J Pediatr Endocrinol 2015;(1):66.
14. Shellhaas RA, Barks AK, Joshi SM. Prevalence and risk factors for vitamin D insufficiency among children with epilepsy. Pediatr Neurol. 2010;42(6):422–6.
15. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004. Pediatrics 2009;124(3):e362–70.
16. Baek J-H, Seo Y-H, Kim G-H, Kim M-K, Eun B-L. Vitamin D Levels in Children and Adolescents with Antiepileptic Drug Treatment. Yonsei Med J2014;55(2):417–21.
17. Tellez-Zenteno JF, Valente KD, Eadie M, Lin W, Liang J, Zhong R, et al. Bone Mineral Density Loss in People With Epilepsy Taking Valproate as a Monotherapy: A Systematic Review and Meta. Anal Front Neurol 2019;10:1171.
How to Cite
Shah A, Khan I, Sherazi S, Ashfaq T, Shah S. Association of long term sodium valproate monotherapy and vitamin D3 levels in epileptic children. JRMC [Internet]. 30Mar.2021 [cited 8Dec.2021];25(1):117-21. Available from: